Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 2/20 | 0.61 |
| ▸ | CXCR4 | P61073 | 10/20 | 0.59 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.57 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.57 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.57 |
| ▸ | MC4R | P32245 | 2/20 | 0.57 |
| ▸ | MC5R | P33032 | 2/20 | 0.57 |
| ▸ | MC3R | P41968 | 2/20 | 0.57 |
| ▸ | MC1R | Q01726 | 2/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.56 |
| ▸ | TACR1 | P25103 | 1/20 | 0.54 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.53 |
| ▸ | NPY2R | P49146 | 1/20 | 0.53 |
| ▸ | NPY4R | P50391 | 1/20 | 0.53 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL3501383 | 0.95 | CXCR4 (0.60) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL30978822 | 0.90 | CXCR4 (0.60) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL31165857 | 0.90 | NTSR2 (0.57) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL29913515 | 0.89 | CXCR4 (0.62) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL29930247 | 0.88 | CXCR4 (0.56) | C5AR1CXCR4MC4RMC5RMC3R | |
| SCHEMBL31232547 | 0.87 | C5AR1 (0.62) | C5AR1CXCR4MC4RMC5RMC3R | |
| SCHEMBL34470399 | 0.87 | NTSR2 (0.66) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL10346020 | 0.87 | CXCR4 (0.63) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL10346018 | 0.87 | CXCR4 (0.63) | C5AR1CXCR4NTSR2NTSR1SORT1 | |
| SCHEMBL31378995 | 0.87 | C5AR1 (0.63) | C5AR1CXCR4NTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119189-A | Polypeptides having MMP2 inhibitory effect | 大正制药株式会社 | 2024-12-13 | — | — | CN | disclosed |
| CN-114450294-B | Polypeptides having MMP2 inhibitory effect | 大正制药株式会社 | 2024-11-26 | — | — | CN | disclosed |
| US-11471490-B2 | T cells surface-loaded with immunostimulatory fusion molecules and uses thereof | TORQUE THERAPEUTICS, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| CN-114450294-A | Polypeptide with MMP2 inhibitory effect | 大正制药株式会社 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11471490-B2 | T cells surface-loaded with immunostimulatory fusion molecules and uses thereof | CD4, ICOS, IL2 | C5AR1 326/4885CXCR4 183/4885NTSR2 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.